Insilico Medicine’s Head of AI Platforms on Revolutionizing Drug Discovery

Petrina Kamya, Head of AI Platforms at Insilico Medicine, explores the potential impact of AI in revolutionizing drug discovery. They discuss the application of AI in drug development, optimization in clinical trial selection, and the need for interdisciplinary collaboration. They also highlight the collaborative effort behind AI innovation in the life sciences.